Effect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis

被引：0
|
作者：
Richard P. Ramonell
Imran H. Iftikhar
机构：
[1] Emory University School of Medicine,Division of Pulmonary, Allergy, Critical Care & Sleep Medicine, Department of Medicine
来源：
Lung | 2020年 / 198卷
关键词：
Eosinophilic asthma; Benralizumab; Dupilumab; Mepolizumab; Reslizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：95 / 103
页数：8
相关论文
共 50 条
  • [21] German Asthma Net: Characterization of responders to anti-IL-5 and anti-IL-5(R) therapy
    Bal, C.
    Milger, K.
    Skowasch, D.
    Schulz, C.
    Jandl, M.
    Schmidt, O.
    Ehmann, R.
    Stoshikj, S.
    Zehetmayer, S.
    Taube, C.
    Hamelmann, E.
    Buhl, R.
    Korn, S.
    Idzko, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 572 - 573
  • [22] Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis
    Rivero, Alexander
    Liang, Jonathan
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2017, 126 (11): : 739 - 747
  • [23] Long-term effectiveness of anti-IL4R therapy following suboptimal response to anti-IL5/5R therapy in severe eosinophilic asthma
    Gates, J.
    Fernandes, M.
    Hearn, A.
    Green, L.
    Thomson, L.
    Roxas, C.
    Lam, J.
    d'Ancona, G.
    Nanzer, A. M.
    Dhariwal, J.
    Jackson, D. J.
    THORAX, 2023, 78 (SUPPL_4) : A47 - A48
  • [24] Mechanisms of Nasal Epithelial Cell Permeability in Eosinophilic Severe Asthma: Effect of Anti-IL5R Therapy
    Raby, K.
    Dixey, P.
    Versi, A.
    Koranteng, J. B.
    Chung, K.
    Bhavsar, P. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [25] Mechanisms of nasal epithelial cell permeability in eosinophilic Severe Asthma: effect of anti-IL5R therapy
    Raby, K.
    Dixey, P.
    Kermani, N. Zounemat
    Koranteng, J.
    Chung, F.
    Bhavsar, P.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [26] Reply to "Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma''
    Eger, Katrien
    Kroes, Johannes A.
    ten Brinke, Anneke
    Bel, Elisabeth H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1936 - 1936
  • [27] Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission
    Carpagnano, Giovanna Elisiana
    Portacci, Andrea
    Nolasco, Santi
    Detoraki, Aikaterini
    Vatrella, Alessandro
    Calabrese, Cecilia
    Pelaia, Corrado
    Montagnolo, Francesca
    Scioscia, Giulia
    Valenti, Giuseppe
    D'Amato, Maria
    Caiaffa, Maria Filomena
    Triggiani, Massimo
    Scichilone, Nicola
    Crimi, Claudia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [28] Determining early response to anti-IL5/IL5R monoclonal antibodies in severe eosinophilic asthma
    Kavanagh, Joanne
    Roxas, Cris
    Green, Linda
    Fernandes, Mariana
    Thomson, Louise
    Payne, Victoria
    Hearn, Andrew
    Kent, Brian D.
    D'Ancona, Grainne
    Dhairwal, Jaideep
    Nanzer, Alexandra M.
    Jackson, David J.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [29] Comparative Efficacy of Anti IL-4, IL-5 and IL-13 Drugs for Treatment of Eosinophilic Asthma: A Network Meta-analysis
    Iftikhar, Imran H.
    Schimmel, Mathew
    Bender, William
    Swenson, Colin
    Amrol, David
    LUNG, 2018, 196 (05) : 517 - 530
  • [30] Comparative Efficacy of Anti IL-4, IL-5 and IL-13 Drugs for Treatment of Eosinophilic Asthma: A Network Meta-analysis
    Imran H. Iftikhar
    Mathew Schimmel
    William Bender
    Colin Swenson
    David Amrol
    Lung, 2018, 196 : 517 - 530
12345